top of page
6 Stocks Likely to Move Big on Rare/Genetic Disease Readouts
A number of rare/genetic disease readouts are set this Q3 2025. Some of them are likely to move big. See table below for 6 of the anticipated readouts. 📈 📉 6 stocks likely to move big on rare/genetic disease readouts in Q3 ‘25 👇  $ARCT ARCT-032 / Cystic Fibrosis / Phase 2 » Safety findings → No SAEs, severe AEs, or dose-limiting toxicities → Dose-related increase in transient, mild, post-dose respiratory symptoms » PK findings: Very low systemic exposure → mRNA: all plas
Jul 16, 2025
Â
Â
Â
6 Stocks Likely to Move Big on Rare/Genetic Disease Readouts
A number of rare/genetic disease readouts are set this Q3 2025. Some of them are likely to move big. See table below for 6 of the anticipated readouts. 📈 📉
Jul 16, 2025
Â
Â
Â
April 2023 Big Moverâ„¢ Stocks and Movers to Watch Report
First posted 3/14/2023; last updated 4/3/23
Mar 14, 2023
Â
Â
Â
Mar 9, 2023
Â
Â
Â
March 2023 Big Moverâ„¢ Stocks and Movers to Watch Report
First posted 2/24/23; updated 4/3/23
Feb 23, 2023
Â
Â
Â


Upcoming Pegozafermin NASH Readout!
Summary: The upcoming readout from ETNB includes Phase 2b data from the pegozafermin trial in NASH. This is a Suspected Mover for Q1...
Feb 22, 2023
Â
Â
Â


Biopharma Mid Morning Pulse - 07/28/22
(Posted 10:15am CST) $XBI $82.01 | -1.67% Table of Contents: Top 10 AM Positive Movers Top 10 AM Negative Movers Top 10 AM Volume Movers...
Jul 28, 2022
Â
Â
Â


Free Biopharma Mid Morning Pulse - 07/28/22
(Posted 10:15am CST) $XBI $82.01 | -1.67% Table of Contents: Top 10 AM Positive Movers Top 10 AM Negative Movers Top 10 AM Volume Movers...
Jul 28, 2022
Â
Â
Â


Biopharma Mid Morning Pulse - 07/26/22
(Posted 10:05am CST) $XBI $80.41 | -0.65% Table of Contents: Top 10 AM Positive Movers Top 10 AM Negative Movers Top 10 AM Volume Movers...
Jul 26, 2022
Â
Â
Â


Free Biopharma Mid Morning Pulse - 07/26/22
(Posted 10:05am CST) $XBI $80.41 | -0.65% Table of Contents: Top 10 AM Positive Movers Top 10 AM Negative Movers Top 10 AM Volume Movers...
Jul 26, 2022
Â
Â
Â


Biopharma Mid Morning Pulse - 07/11/22
(Posted 10am CST) $XBI $81.76 | -3.16% Table of Contents: Top 10 AM Positive Movers Top 10 AM Negative Movers Top 10 AM Volume Movers...
Jul 11, 2022
Â
Â
Â


Free Biopharma Mid Morning Pulse - 07/11/22
(Posted 10am CST) $XBI $81.76 | -3.16% Table of Contents: Top 10 AM Positive Movers Top 10 AM Negative Movers Top 10 AM Volume Movers...
Jul 11, 2022
Â
Â
Â


Biopharma Daily Stock Updates - 06/27/22
$XBI $76.80 | -0.34% Table of Contents: Pipeline Updates Business Updates Covid Updates #BNTX +7.2% Pfizer and BioNTech Announce...
Jun 27, 2022
Â
Â
Â


Free Biopharma Daily Stock Updates - 06/27/22
$XBI $76.80 | -0.34% Table of Contents: Pipeline Updates Business Updates Covid Updates #BNTX +7.2% Pfizer and BioNTech Announce...
Jun 27, 2022
Â
Â
Â


Biopharma Daily Stock Updates - 06/21/22
$XBI $70.03 | +3.58% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates #OCGN +4.6% Ocugen Announces...
Jun 21, 2022
Â
Â
Â


Free Biopharma Daily Stock Updates - 06/21/22
$XBI $70.03 | +3.58% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates #OCGN +4.6% Ocugen Announces...
Jun 21, 2022
Â
Â
Â


Biopharma Daily Stock Updates - 06/13/22
$XBI $63.32 | -5.53% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates #NVAX -10.7% Novavax COVID-19...
Jun 13, 2022
Â
Â
Â


Free Biopharma Daily Stock Updates - 06/13/22
$XBI $63.32 | -5.53% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates #NVAX -10.7% Novavax COVID-19...
Jun 13, 2022
Â
Â
Â


Biopharma Daily Stock Updates - 06/03/22
$XBI $71.21 | +3.55% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates #NVAX -20% Novavax Statement on...
Jun 3, 2022
Â
Â
Â


Free Biopharma Daily Stock Updates - 06/03/22
$XBI $71.21 | +3.55% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates #NVAX -20% Novavax Statement on...
Jun 3, 2022
Â
Â
Â
Jump start your biotech due diligence
Our platform helps you uncover your next biotech investment opportunity
bottom of page
